KCSG BR15-10유방암
Palbociclib plus endocrine therapy versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (Young-PEARL): overall survival analysis of a randomised, open-label, phase 2 study
- 저널 Lancet Oncol. 2025 Mar;26(3):343-354.
- 제1저자 안희경, 김지연
- 교신저자 박연희, 임석아